Saltar al contenido principal

Clinical Trial Workflow and Data Integration

This page describes the end-to-end workflow for alopecia severity assessment in a clinical trial using the Legit.Health platform, from protocol design through to EDC data delivery.

Workflow overview

The clinical trial workflow consists of eight stages:

  1. Protocol design: Configure the study with Legit.Health
  2. Site setup: Deploy the platform to investigator sites
  3. Patient enrollment: Register patients in the platform
  4. Image capture: Guided 4-quadrant scalp photography at the site
  5. AI scoring: Automated ASALT computation
  6. Report review: Investigator reviews the severity report
  7. Severity tracking and alerts: Longitudinal monitoring with automated notifications
  8. Data export: Structured delivery to EDC systems

1. Protocol design

Before the study begins, Legit.Health works with the sponsor or CRO to configure the study protocol:

Configuration itemOptionsExample
Imaging perspectives4-quadrant standard, custom4 quadrants (left, right, top, back)
EndpointsTotal ASALT, regional ASALT, severity classification, SALT response (any combination)Total ASALT + severity classification + SALT 50/75/90/100
Alert thresholdsConfigurable percentage increase from baseline for automated notifications≥25% increase from baseline triggers site notification
DIQA thresholdStrict (pivotal) or lenient (RWE)Strict for Phase III
Data export formatAPI, CSV, CRF-mapped fieldsCRF-mapped to sponsor’s EDC

A study-specific investigator manual is generated for each trial, providing site personnel with step-by-step instructions, example images, and a knowledge test to confirm training.

2. Site setup

The Legit.Health clinical trials platform is deployed as a web application accessible from any browser. Each investigator site receives:

  • Login credentials for all study personnel
  • Pre-configured protocol (perspectives, endpoints, alert thresholds)
  • Investigator manual (digital, accessible from the platform)
  • Training resources and knowledge test

No hardware installation is required; investigators use their existing smartphones for image capture.

3. Patient enrollment

After enrolling a patient in the study per the clinical protocol, the investigator creates the patient record in the Legit.Health platform:

Add new

Select the body area(s)

Select the most common

Do you want to track this condition?

Add condition

Each patient is identified by a study-specific pseudonymised identifier; no personal data (name, date of birth) is stored in the platform.

4. Image capture

The investigator captures photographs of the patient's scalp using the Legit.Health mobile application:

The application provides:

  • Perspective guidance: Visual silhouettes showing the required capture angle for each of the four scalp quadrants
  • Real-time DIQA quality check: Each image is evaluated for focus, lighting, framing, and resolution immediately after capture
  • Immediate feedback: If an image fails quality standards, the investigator is prompted to recapture with specific guidance
  • Confirmation: Once all four perspectives pass quality checks, the images are submitted for AI processing

For the standard 4-quadrant protocol, the entire capture process takes approximately 60–90 seconds.

5. AI scoring

Once images are submitted, the AI processes them automatically. Processing takes approximately ~2 seconds for 4 images combined. The system produces:

  • Per-quadrant hair loss percentage (left, right, top, back)
  • Per-quadrant ASALT score weighted by regional proportion
  • Total ASALT score (0–100)
  • Severity classification (None / Limited / Moderate / Severe / Very Severe)
  • SALT response flags (SALT 50/75/90/100 vs. baseline, when applicable)
  • DIQA quality score per image

ASALT

Score: 55

Severe

Report Information

Timestamp

3/24/2026, 2:16:32 AM

Analysis performed in

1.2 seconds

Status

Not reviewed

Left of the head
Limited

Body site

Left of the head

p]:mb-0>

Image quality

68%

Right of the head
Severe

Body site

Right of the head

p]:mb-0>

Image quality

66%

Top of the head
Severe

Body site

Top of the head

p]:mb-0>

Image quality

63%

Back of the head
Limited

Body site

Back of the head

p]:mb-0>

Image quality

55%

The report is immediately available for the investigator to review.

6. Report review

The investigator reviews the severity report directly in the platform. The report includes:

  • Total ASALT score: Global SALT score (0–100) with severity classification
  • Per-quadrant breakdown: Regional hair loss percentages and ASALT contributions for each of the four quadrants
  • Image quality: DIQA score for each captured image

The investigator can verify that the AI's assessment aligns with their clinical observation. If the images are inadequate, the investigator can recapture and resubmit; only the latest submission for each visit is retained.

7. Severity tracking and automated alerts

For follow-up visits, the platform tracks severity evolution across all assessments for the patient.

Longitudinal tracking

The platform displays:

  • ASALT score evolution over time with visual comparison to baseline
  • Absolute and percentage change from baseline at each visit
  • SALT response classification (SALT 50/75/90/100) when applicable
  • Trend visualisation for identifying treatment response or progression

Automated alert system

The system can be configured to trigger automated email notifications when clinically significant changes are detected:

  • Configurable threshold: Default is >=25% increase in ASALT from baseline (adjustable per study protocol)
  • Automatic notification: Site receives an email alert when the threshold is met
  • Site action: The investigator confirms the finding through clinical assessment
  • Escalation: If confirmed (e.g., as an adverse event), enhanced monitoring can be initiated per the study protocol
Alert precision

The alert threshold is inclusive (>=25%, not >25%). This is a deliberate design choice to ensure that borderline cases are flagged for clinical review rather than missed.

8. Data export and EDC integration

Assessment results are structured for integration with the sponsor's EDC (Electronic Data Capture) system.

Exported data fields

FieldDescriptionFormat
Patient identifierStudy-specific pseudonymised IDString
Visit dateDate and timestamp of the assessmentISO 8601
Total ASALT scoreGlobal SALT score (0–100)Float
Regional ASALT scoresASALT score per quadrant (left, right, top, back)Float (0–100) per region
Severity classificationNone / Limited / Moderate / Severe / Very SevereString
SALT response flagsBinary flags for SALT 50, SALT 75, SALT 90, SALT 100 response vs. baselineBoolean per threshold
Change from baselineAbsolute and percentage change in ASALT from baselineFloat
DIQA scoresImage quality score per perspectiveFloat
Alert triggeredWhether the assessment triggered an automated notification based on thresholdBoolean

Integration methods

  • API-based: Automated data flow from the Legit.Health platform to the sponsor’s EDC system via RESTful API
  • CSV export: Structured CSV files for manual import into EDC systems
  • CRF field mapping: Data fields pre-mapped to the sponsor’s Case Report Form structure, configured during protocol design
  • QuantifiCare platform integration: For studies using the combined QuantifiCare + Legit.Health solution, scoring data flows through QuantifiCare’s platform to the sponsor’s data management system

All exported data is structured for direct mapping to CRF fields in standard EDC systems (Medidata Rave, Veeva Vault CDMS, Oracle InForm, etc.).

The integration is API-based and system-agnostic; it works with any EDC system (Medidata Rave, Oracle InForm, Veeva Vault EDC, and others). Export formats include RESTful API, CSV/Excel, and structured JSON. Legit.Health provides IQ/OQ validation documentation and data mapping specifications to support the sponsor's integration validation activities.

Decentralised and hybrid trial support

Hybrid designs

Some study designs combine investigator-captured and patient-captured images:

  • Investigator timepoints: Primary visits (e.g., baseline, month 3, month 6, month 12) where images are captured by trained site personnel at the clinic
  • Patient timepoints: Intermediate visits (e.g., monthly check-ins) where the patient captures images at home using the mobile application

The same AI scoring pipeline processes both types of images. DIQA quality control is applied identically, ensuring that patient-captured images meet the same quality standards as investigator-captured images.

Remote patient capture

For fully decentralised protocols:

  • Patients download the Legit.Health mobile application
  • The app guides them through the capture process with the same perspective silhouettes and DIQA quality checks used at investigator sites
  • Captured images are transmitted securely to the platform for AI scoring
  • The investigator can review scores remotely

Benefits for sponsors

  • Reduced site burden: Fewer in-clinic visits needed for severity assessment
  • Increased data frequency: More timepoints without increasing site workload
  • Patient convenience: Assessments from home reduce travel burden
  • Continuous monitoring: More frequent assessments enable finer-grained treatment response detection

For alopecia trials, decentralised capture is particularly relevant: patients can capture scalp photographs at home following the standardised protocol, enabling more frequent assessments without requiring in-clinic visits. The DIQA quality gate ensures that home-captured images meet the same quality standards as site-captured images.